522 related articles for article (PubMed ID: 17378815)
21. Prevention of cervical cancer with screening programme in Branicevo District and cost-effectiveness analysis adjusted to the territory of the Republic of Serbia.
Perovic S
J BUON; 2009; 14(1):93-6. PubMed ID: 19373953
[TBL] [Abstract][Full Text] [Related]
22. Cervical cytology and the evaluation of the abnormal Papanicolaou smear.
Noller KL
Prim Care; 1988 Sep; 15(3):461-71. PubMed ID: 3054958
[TBL] [Abstract][Full Text] [Related]
23. A 2-year follow-up study of anxiety and depression in women referred for colposcopy after an abnormal cervical smear.
Hellsten C; Sjöström K; Lindqvist PG
BJOG; 2008 Jan; 115(2):212-8. PubMed ID: 18081601
[TBL] [Abstract][Full Text] [Related]
24. A longitudinal 2-year follow-up of quality of life in women referred for colposcopy after an abnormal cervical smear.
Hellsten C; Sjöström K; Lindqvist PG
Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):221-5. PubMed ID: 19782459
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the Papanicolaou smear and the cervigram: sensitivity, specificity, and cost analysis.
Tawa K; Forsythe A; Cove JK; Saltz A; Peters HW; Watring WG
Obstet Gynecol; 1988 Feb; 71(2):229-35. PubMed ID: 3336558
[TBL] [Abstract][Full Text] [Related]
26. Management of women with mild and moderate cervical dyskaryosis.
Flannelly G; Anderson D; Kitchener HC; Mann EM; Campbell M; Fisher P; Walker F; Templeton AA
BMJ; 1994 May; 308(6941):1399-403. PubMed ID: 8019248
[TBL] [Abstract][Full Text] [Related]
27. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading.
Priest P; Sadler L; Peters J; Crengle S; Bethwaite P; Medley G; Jackson R
BJOG; 2007 Apr; 114(4):398-407. PubMed ID: 17166215
[TBL] [Abstract][Full Text] [Related]
28. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
[TBL] [Abstract][Full Text] [Related]
29. Cytology, colposcopy and cervical neoplasia.
MacLean AB; Lay MP; Kelleher PR; Carnielo RJ
N Z Med J; 1985 Sep; 98(786):756-8. PubMed ID: 3863056
[TBL] [Abstract][Full Text] [Related]
30. Psychological response to cervical screening.
Bell S; Porter M; Kitchener H; Fraser C; Fisher P; Mann E
Prev Med; 1995 Nov; 24(6):610-6. PubMed ID: 8610085
[TBL] [Abstract][Full Text] [Related]
31. Cervical cytology during pregnancy--comparison with non-pregnant women and management of pregnant women with abnormal cytology.
Morimura Y; Fujimori K; Soeda S; Hashimoto T; Takano Y; Yamada H; Yanagida K; Sato A
Fukushima J Med Sci; 2002 Jun; 48(1):27-37. PubMed ID: 12365596
[TBL] [Abstract][Full Text] [Related]
32. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
33. Resource use and cost analysis of managing abnormal Pap smears: a retrospective study in five countries.
Rash B; Martin-Hirsch P; Schneider A; Sideri M; Tan J; Torné A; Standaert B
Eur J Gynaecol Oncol; 2008; 29(3):225-32. PubMed ID: 18592784
[TBL] [Abstract][Full Text] [Related]
34. Is a policy of cervical screening for all women attending a genito-urinary medicine clinic justified?
Stedman Y; Woodman CB; Donnelly BJ
J Public Health Med; 1995 Mar; 17(1):90-2. PubMed ID: 7786575
[TBL] [Abstract][Full Text] [Related]
35. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
Kim JJ; Leung GM; Woo PP; Goldie SJ
J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
[TBL] [Abstract][Full Text] [Related]
37. Cervical screening in general practice: call and recall.
Ridsdale LL
J R Coll Gen Pract; 1987 Jun; 37(299):257-9. PubMed ID: 3129556
[TBL] [Abstract][Full Text] [Related]
38. Four and a half year follow up of women with dyskaryotic cervical smears.
Fletcher A; Metaxas N; Grubb C; Chamberlain J
BMJ; 1990 Sep; 301(6753):641-4. PubMed ID: 2224218
[TBL] [Abstract][Full Text] [Related]
39. A decision analysis of practice patterns used in evaluating and treating abnormal Pap smears.
Roland PY; Naumann RW; Alvarez RD; Kilgore LC; Partridge EE
Gynecol Oncol; 1995 Oct; 59(1):75-80. PubMed ID: 7557619
[TBL] [Abstract][Full Text] [Related]
40. Clinical management of abnormal cytology test results and costs associated with the prevention of cervical cancer in Spain.
Blade A; Cararach M; Castro M; Catalá-López F; Pérez-Escolano I; de Sanjosé S
J Low Genit Tract Dis; 2010 Oct; 14(4):311-8. PubMed ID: 20885158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
